Longwei Xu

898 total citations
18 papers, 740 citations indexed

About

Longwei Xu is a scholar working on Molecular Biology, Surgery and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Longwei Xu has authored 18 papers receiving a total of 740 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 5 papers in Surgery and 4 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Longwei Xu's work include Circadian rhythm and melatonin (4 papers), Ubiquitin and proteasome pathways (3 papers) and Mitochondrial Function and Pathology (2 papers). Longwei Xu is often cited by papers focused on Circadian rhythm and melatonin (4 papers), Ubiquitin and proteasome pathways (3 papers) and Mitochondrial Function and Pathology (2 papers). Longwei Xu collaborates with scholars based in China, Singapore and United States. Longwei Xu's co-authors include Jun Pu, Ben He, Yuanyuan Su, Lingchen Gao, Yichao Zhao, Nan Lin, Ancai Yuan, Song Ding, Xiaoying Ying and Renyang Tong and has published in prestigious journals such as PLoS ONE, Hepatology and Scientific Reports.

In The Last Decade

Longwei Xu

17 papers receiving 737 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Longwei Xu China 13 369 151 141 127 110 18 740
Lingchen Gao China 14 347 0.9× 123 0.8× 137 1.0× 107 0.8× 62 0.6× 18 635
Yinli Xu China 15 488 1.3× 109 0.7× 206 1.5× 109 0.9× 69 0.6× 34 953
Weijian Hang China 17 363 1.0× 36 0.2× 236 1.7× 115 0.9× 108 1.0× 30 835
Pimonrat Ketsawatsomkron United States 19 404 1.1× 48 0.3× 180 1.3× 82 0.6× 63 0.6× 28 827
Yuzhen Li China 14 324 0.9× 91 0.6× 52 0.4× 103 0.8× 54 0.5× 46 684
Ruijuan Guan China 17 310 0.8× 76 0.5× 59 0.4× 63 0.5× 93 0.8× 33 853
Sarah Will United States 15 239 0.6× 64 0.4× 70 0.5× 130 1.0× 109 1.0× 28 626
Tomohiko Sasase Japan 20 390 1.1× 82 0.5× 43 0.3× 104 0.8× 194 1.8× 67 1.0k
Melissa Kazantzis United States 14 452 1.2× 106 0.7× 54 0.4× 249 2.0× 133 1.2× 19 1.0k

Countries citing papers authored by Longwei Xu

Since Specialization
Citations

This map shows the geographic impact of Longwei Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Longwei Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Longwei Xu more than expected).

Fields of papers citing papers by Longwei Xu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Longwei Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Longwei Xu. The network helps show where Longwei Xu may publish in the future.

Co-authorship network of co-authors of Longwei Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Longwei Xu. A scholar is included among the top collaborators of Longwei Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Longwei Xu. Longwei Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
2.
Liu, Hengdao, et al.. (2024). Gramine improves sepsis-induced myocardial dysfunction by binding to NF-κB p105 and inhibiting its ubiquitination. Phytomedicine. 125. 155325–155325. 6 indexed citations
3.
Xu, Longwei, et al.. (2023). Gramine protects against pressure overload-induced pathological cardiac hypertrophy through Runx1-TGFBR1 signaling. Phytomedicine. 114. 154779–154779. 7 indexed citations
4.
Xu, Longwei, et al.. (2023). [Relationship between coronavirus disease 2019 vaccination and the risk of immune thrombocytopenia].. PubMed. 25(9). 966–970. 1 indexed citations
5.
Xu, Longwei, Yuanyuan Su, Yichao Zhao, et al.. (2019). Melatonin differentially regulates pathological and physiological cardiac hypertrophy: Crucial role of circadian nuclear receptor RORα signaling. Journal of Pineal Research. 67(2). e12579–e12579. 59 indexed citations
6.
Ding, Song, Nan Lin, Yichao Zhao, et al.. (2019). Melatonin stabilizes rupture‐prone vulnerable plaques via regulating macrophage polarization in a nuclear circadian receptor RORα‐dependent manner. Journal of Pineal Research. 67(2). e12581–e12581. 93 indexed citations
7.
Gao, Yi, Yichao Zhao, Ancai Yuan, et al.. (2018). Effects of farnesoid-X-receptor SUMOylation mutation on myocardial ischemia/reperfusion injury in mice. Experimental Cell Research. 371(2). 301–310. 20 indexed citations
8.
Peng, Shi, Longwei Xu, Qingqing Xiao, et al.. (2018). Atorvastatin Inhibits Inflammatory Response, Attenuates Lipid Deposition, and Improves the Stability of Vulnerable Atherosclerotic Plaques by Modulating Autophagy. Frontiers in Pharmacology. 9. 438–438. 89 indexed citations
9.
Zhao, Yichao, Fang Wang, Lingchen Gao, et al.. (2018). Ubiquitin‐Specific Protease 4 Is an Endogenous Negative Regulator of Metabolic Dysfunctions in Nonalcoholic Fatty Liver Disease in Mice. Hepatology. 68(3). 897–917. 47 indexed citations
10.
Gao, Lingchen, Yichao Zhao, Jie He, et al.. (2017). The desumoylating enzyme sentrin-specific protease 3 contributes to myocardial ischemia reperfusion injury. Journal of genetics and genomics. 45(3). 125–135. 27 indexed citations
11.
Zhao, Yichao, Longwei Xu, Song Ding, et al.. (2016). Nuclear receptor retinoid-related orphan receptor α deficiency exacerbates high-fat diet-induced cardiac dysfunction despite improving metabolic abnormality. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1863(8). 1991–2000. 15 indexed citations
13.
Zhao, Yichao, Longwei Xu, Song Ding, et al.. (2016). Novel protective role of the circadian nuclear receptor retinoic acid‐related orphan receptor‐α in diabetic cardiomyopathy. Journal of Pineal Research. 62(3). 61 indexed citations
14.
He, Ben, Yichao Zhao, Longwei Xu, et al.. (2016). The nuclear melatonin receptor RORα is a novel endogenous defender against myocardial ischemia/reperfusion injury. Journal of Pineal Research. 60(3). 313–326. 128 indexed citations
15.
Ying, Xiaoying, Yichao Zhao, Ancai Yuan, et al.. (2016). Novel Protective Role for Ubiquitin-Specific Protease 18 in Pathological Cardiac Remodeling. Hypertension. 68(5). 1160–1170. 41 indexed citations
16.
He, Ben, Yichao Zhao, Lingchen Gao, et al.. (2016). Ubiquitin-Specific Protease 4 Is an Endogenous Negative Regulator of Pathological Cardiac Hypertrophy. Hypertension. 67(6). 1237–1248. 46 indexed citations
18.
He, Qing, Jun Pu, Ancai Yuan, et al.. (2014). Liver X receptor agonist treatment attenuates cardiac dysfunction in type 2 diabetic db/db mice. Cardiovascular Diabetology. 13(1). 149–149. 46 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026